Crestor was Approved by FDA for High Cholesterol Kids
Written by WTJ on October 19, 2009 – 2:37 pm -
Crestor, a cholesterol drug designed, was approved by the Food and Drug Administration on Friday for children and teenagers with high cholesterol caused by genetic disease. Crestor was developed by the company AstraZeneca PLC. The drug is suitable for heterozygous familial hypercholesterolemia patients age 10 to 17. Currently there are 10 million people worldwide affected by the genetic disease. Crestor generated $3.6 billion sales for AstraZeneca in 2008. The patents of the drug will expire in July 2016.
(news)
Related posts:
Tags: AstraZeneca, AstraZeneca PLC, cholesterol, cholesterol drug, crestor, drug, FDA, food and drug administration | No Comments »
